NCT07154303

Brief Summary

The purpose of this 4-in-1 observational study is to test the performance of artificial intelligences (AIs) in distinguishing irregularly irregular heart rhythm called atrial fibrillation (AF) from normal heart rhythm using physiological signals collected by smartphones' built-in hardware and/or external accessories. Participants will:

  • Have their weight, height, resting heart rate and blood pressures measured
  • Have 12-lead electrocardiogram (ECG) of their heart electrical activities recorded
  • Have their heart sounds and 1-lead ECG recorded from their chest, and optical-based blood flow data (photoplethysmography or PPG) and 1-lead ECG recorded from their fingers using smartphones' built-in microphone, camera, and/or external accessories
  • Optionally have their optical-based blood flow data recorded from their face using smartphones' built-in camera (remote PPG or rPPG). The researchers will also create a database containing the physiological signals collected in this study along with the participants' medically relevant information to help train and test future AIs for medical applications.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
209

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Aug 2025Oct 2026

First Submitted

Initial submission to the registry

August 26, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

August 27, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

December 31, 2025

Status Verified

December 1, 2025

Enrollment Period

11 months

First QC Date

August 26, 2025

Last Update Submit

December 24, 2025

Conditions

Keywords

SmartphonePersistent Atrial FibrillationMobile HealthmHealthTelemedicineArtificial IntelligenceHeart SoundsPhonocardiographyPhotoplethysmographyElectrocardiography12-Lead ECG12-Lead EKG12-Lead ElectrocardiographyECGEKGElectrocardiogramElectrocardiograph

Outcome Measures

Primary Outcomes (1)

  • Differentiation of Atrial Fibrillation from Sinus Rhythm in Heart Sound Recordings

    AUSC-AF: Identification of atrial fibrillation (AF) from sinus rhythm in recorded heart sounds (phonocardiogram \[PCG\]) as verified by the gold standard 12-lead electrocardiography (ECG) interpretation, measured in the form of sensitivity and specificity.

    Day 0

Secondary Outcomes (4)

  • Differentiation of Atrial Fibrillation from Sinus Rhythm in Heart Sound Recordings

    Day 0

  • Differentiation of Atrial Fibrillation from Sinus Rhythm in 1-Lead ECG Signals

    Day 0

  • Differentiation of Atrial Fibrillation from Sinus Rhythm in PCG and 1-Lead ECG Signals

    Day 0

  • Differentiation of Atrial Fibrillation from Sinus Rhythm in Facial Photoplethysmography Signals

    Day 0

Study Arms (2)

Atrial Fibrillation

Diagnostic Test: Computer algorithms

Sinus Rhythm

Diagnostic Test: Computer algorithms

Interventions

Computer algorithmsDIAGNOSTIC_TEST

Computer algorithms that are designed to perform heart sound, electrocardiography (ECG), and/or facial photoplethysmography (rPPG) analysis on data collected from smartphone's internal hardware and/or external accessories.

Also known as: ausculto®, Vitogram®, FacialAI
Atrial FibrillationSinus Rhythm

Eligibility Criteria

Age22 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospital cardiology patients

You may qualify if:

  • Age: ≥22 years (adult)
  • Patients who have one of the following:
  • Permanent atrial fibrillation, or
  • Long-standing persistent atrial fibrillation (12 months or longer), or
  • Confirmed 12-lead ECG diagnosis for persistent atrial fibrillation (\> 7 days) or sinus rhythm within 12 months at the time of their normal attendance at the hospital

You may not qualify if:

  • Any of the following:
  • Implanted active medical devices in the torso, such as pacemakers and defibrillators
  • Patients without atrial fibrillation who have another arrhythmia
  • Completely missing one or more limbs, or missing any hand
  • Disability in using their hands or arms
  • Lack of both index fingers, or all fingers in any hand
  • Both index fingers with any of the following characteristics:
  • Tattooed/inked
  • Reduced blood flow in the fingertip (e.g. perniosis or callus formation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Mary Hospital

Hong Kong, China

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

August 26, 2025

First Posted

September 4, 2025

Study Start

August 27, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

December 31, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations